PL194750B1 - Kompozycja farmaceutyczna zawierająca indole i estrogeny, jej zastosowanie oraz produkt - Google Patents

Kompozycja farmaceutyczna zawierająca indole i estrogeny, jej zastosowanie oraz produkt

Info

Publication number
PL194750B1
PL194750B1 PL99345268A PL34526899A PL194750B1 PL 194750 B1 PL194750 B1 PL 194750B1 PL 99345268 A PL99345268 A PL 99345268A PL 34526899 A PL34526899 A PL 34526899A PL 194750 B1 PL194750 B1 PL 194750B1
Authority
PL
Poland
Prior art keywords
methyl
alkyl
benzyl
phenyl
pharmaceutically acceptable
Prior art date
Application number
PL99345268A
Other languages
English (en)
Polish (pl)
Other versions
PL345268A1 (en
Inventor
James Harrison Pickar
Barry Samuel Komm
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22151320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL194750(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PL345268A1 publication Critical patent/PL345268A1/xx
Publication of PL194750B1 publication Critical patent/PL194750B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL99345268A 1998-05-15 1999-05-11 Kompozycja farmaceutyczna zawierająca indole i estrogeny, jej zastosowanie oraz produkt PL194750B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7956198A 1998-05-15 1998-05-15
PCT/US1999/010217 WO1999059581A1 (en) 1998-05-15 1999-05-11 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens

Publications (2)

Publication Number Publication Date
PL345268A1 PL345268A1 (en) 2001-12-03
PL194750B1 true PL194750B1 (pl) 2007-06-29

Family

ID=22151320

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99345268A PL194750B1 (pl) 1998-05-15 1999-05-11 Kompozycja farmaceutyczna zawierająca indole i estrogeny, jej zastosowanie oraz produkt

Country Status (41)

Country Link
EP (1) EP1076558B1 (forum.php)
JP (3) JP2002515431A (forum.php)
KR (1) KR100620772B1 (forum.php)
CN (1) CN1230163C (forum.php)
AP (1) AP1424A (forum.php)
AR (1) AR020074A1 (forum.php)
AT (1) ATE245026T1 (forum.php)
AU (1) AU760378B2 (forum.php)
BE (1) BE2015C026I2 (forum.php)
BG (1) BG64783B1 (forum.php)
BR (1) BR9911040A (forum.php)
CA (1) CA2329530A1 (forum.php)
CU (1) CU23241B7 (forum.php)
CY (1) CY2015020I1 (forum.php)
CZ (1) CZ299334B6 (forum.php)
DE (1) DE69909616T2 (forum.php)
DK (1) DK1076558T3 (forum.php)
EA (1) EA005932B1 (forum.php)
EE (1) EE04262B1 (forum.php)
ES (1) ES2203131T3 (forum.php)
FR (1) FR15C0035I2 (forum.php)
GE (1) GEP20033079B (forum.php)
HR (1) HRP20000778B1 (forum.php)
HU (2) HU226587B1 (forum.php)
ID (1) ID26890A (forum.php)
IL (1) IL139130A (forum.php)
IN (1) IN192220B (forum.php)
LT (1) LTC1076558I2 (forum.php)
LU (1) LU92699I2 (forum.php)
NO (2) NO328129B1 (forum.php)
NZ (1) NZ508200A (forum.php)
OA (1) OA11552A (forum.php)
PL (1) PL194750B1 (forum.php)
PT (1) PT1076558E (forum.php)
SI (1) SI1076558T1 (forum.php)
SK (1) SK284666B6 (forum.php)
TR (1) TR200003377T2 (forum.php)
TW (1) TW565554B (forum.php)
UA (1) UA66861C2 (forum.php)
WO (1) WO1999059581A1 (forum.php)
ZA (1) ZA200006959B (forum.php)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA005932B1 (ru) * 1998-05-15 2005-08-25 Уайт 2-фенил-1-[4-(2-аминоэтокси)бензил]индол в комбинации с эстрогенами
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
PL208972B1 (pl) 1999-07-06 2011-07-29 Endorech Zastosowanie selektywnego modulatora receptora estrogenu
US20020013327A1 (en) * 2000-04-18 2002-01-31 Lee Andrew G. Compositions and methods for treating female sexual dysfunction
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
US6455568B2 (en) 2000-07-06 2002-09-24 Wyeth Combination therapy for inhibiting sphincter incontinence
CN1468110A (zh) * 2000-07-06 2004-01-14 惠氏公司 他汀类、雌激素药物以及任选雌激素的联合应用
CN1450913A (zh) * 2000-07-06 2003-10-22 惠氏公司 二膦酸酯、雌激素药物以及任选雌激素的联合应用
WO2002003992A2 (en) * 2000-07-06 2002-01-17 Wyeth Use of substituted indole compounds for treating prosthesis-related bone degeneration
WO2002003989A2 (en) * 2000-07-06 2002-01-17 Wyeth Use of substituted indole compounds for treating sphincter incontinence
DE10117441A1 (de) * 2001-04-03 2002-10-10 Schering Ag 1-Indolylderivate, deren Verwendung zur Herstellung von Arzneimitteln, ein Verfahren zur Herstellung der 1-Indolylderivate sowie 1-Indolylderivate enthaltende pharmzeutische Präparate
PL367094A1 (en) 2001-07-31 2005-02-21 Pfizer Products Inc. Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
KR100470274B1 (ko) 2002-11-08 2005-02-05 진 장 덮개층을 이용한 비정질 물질의 상 변화 방법
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
FR2880625B1 (fr) * 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
MX2010011408A (es) 2008-04-16 2010-12-20 Karobio Ab Ligandos de receptor de estrogeno novedosos.
AR072297A1 (es) * 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
GB201113538D0 (en) 2011-08-04 2011-09-21 Karobio Ab Novel estrogen receptor ligands
CN102690225B (zh) * 2012-04-11 2014-12-24 南京友杰医药科技有限公司 巴多昔芬的合成方法
CN103709090A (zh) * 2014-01-16 2014-04-09 江苏万特制药有限公司 醋酸巴多昔芬的制备方法及其关键中间体
CN103739540B (zh) * 2014-01-20 2016-05-04 华润赛科药业有限责任公司 一种醋酸巴多昔芬中间体的制备方法
CN105669518B (zh) * 2014-12-04 2019-06-04 上海医药集团股份有限公司 醋酸巴多昔芬及其a晶型的制备方法
MX2020006093A (es) * 2017-12-15 2020-08-24 Bristol Myers Squibb Co Compuestos de indol eter sustituidos.
IT201800006562A1 (it) * 2018-06-21 2019-12-21 Procedimento e intermedi utili per la preparazione di indoli
JP2023517393A (ja) * 2020-03-17 2023-04-25 メッドシャイン ディスカバリー インコーポレイテッド タンパク質分解調整剤およびその使用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency
WO1993023374A1 (en) * 1992-05-08 1993-11-25 Otsuka Pharmaceutical Factory, Inc. Indole derivative
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
GB9326332D0 (en) * 1993-12-23 1994-02-23 Karo Bio Indole derivatives
DE4426625A1 (de) * 1994-07-27 1996-03-14 Schering Ag 2-Phenylindole, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
PT802183E (pt) * 1996-04-19 2002-03-28 American Home Prod Agentes estrogenicos
TW397821B (en) * 1996-04-19 2000-07-11 American Home Produits Corp 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
JP2000514074A (ja) * 1996-07-09 2000-10-24 スミスクライン・ビーチャム・ソシエタ・ペル・アチオニ 骨粗鬆症の治療のためのインドール誘導体
US5672609A (en) * 1996-07-18 1997-09-30 Eli Lilly And Company Pyridine compounds, intermediates compositions and methods of use
ATE355264T1 (de) * 1997-10-15 2006-03-15 Wyeth Corp Neue aryloxy-alkyl-dialkylamine
CA2308069A1 (en) * 1997-10-28 1999-05-06 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
ID24568A (id) * 1997-11-06 2000-07-27 American Home Prod Kontrasepsi oral yang mengandung anti-estrogen plus progestin
EA005932B1 (ru) * 1998-05-15 2005-08-25 Уайт 2-фенил-1-[4-(2-аминоэтокси)бензил]индол в комбинации с эстрогенами

Also Published As

Publication number Publication date
NO2015015I2 (no) 2015-06-02
PT1076558E (pt) 2003-11-28
SI1076558T1 (en) 2003-10-31
NO20005770D0 (no) 2000-11-14
CY2015020I1 (el) 2020-05-29
NO20005770L (no) 2001-01-12
ES2203131T3 (es) 2004-04-01
BE2015C026I2 (en) 2018-08-24
CU23241B7 (es) 2007-10-17
LTC1076558I2 (lt) 2016-11-10
WO1999059581A1 (en) 1999-11-25
ATE245026T1 (de) 2003-08-15
HRP20000778A2 (en) 2001-06-30
PL345268A1 (en) 2001-12-03
HUP0103096A2 (hu) 2002-05-29
EA005932B1 (ru) 2005-08-25
EP1076558A1 (en) 2001-02-21
JP2002515431A (ja) 2002-05-28
ZA200006959B (en) 2001-11-27
JP2014159472A (ja) 2014-09-04
EE200000652A (et) 2002-04-15
FR15C0035I2 (fr) 2015-08-28
NZ508200A (en) 2003-09-26
HUP0103096A3 (en) 2002-11-28
AP1424A (en) 2005-06-06
CZ299334B6 (cs) 2008-06-25
UA66861C2 (uk) 2004-06-15
AU760378B2 (en) 2003-05-15
EP1076558B1 (en) 2003-07-16
SK17202000A3 (sk) 2001-07-10
OA11552A (en) 2004-06-07
CA2329530A1 (en) 1999-11-25
JP2009019042A (ja) 2009-01-29
TR200003377T2 (tr) 2001-03-21
KR20010043641A (ko) 2001-05-25
TW565554B (en) 2003-12-11
HRP20000778B1 (en) 2004-10-31
HUS1500023I1 (hu) 2017-03-28
BG64783B1 (bg) 2006-04-28
AU3894499A (en) 1999-12-06
IL139130A (en) 2005-11-20
NO2015015I1 (no) 2015-06-02
BG104930A (en) 2001-07-31
CN1326347A (zh) 2001-12-12
IN192220B (forum.php) 2004-03-20
HK1031691A1 (en) 2001-06-22
DK1076558T3 (da) 2003-11-03
NO328129B1 (no) 2009-12-14
HU226587B1 (en) 2009-04-28
ID26890A (id) 2001-02-15
JP5607871B2 (ja) 2014-10-15
DE69909616D1 (de) 2003-08-21
IL139130A0 (en) 2001-11-25
GEP20033079B (en) 2003-10-27
CN1230163C (zh) 2005-12-07
EA200001193A1 (ru) 2001-12-24
KR100620772B1 (ko) 2006-09-13
DE69909616T2 (de) 2004-06-17
FR15C0035I1 (forum.php) 2015-06-26
EE04262B1 (et) 2004-04-15
AP2000001970A0 (en) 2000-12-31
BR9911040A (pt) 2001-02-13
AR020074A1 (es) 2002-04-10
JP5872624B2 (ja) 2016-03-01
LU92699I2 (fr) 2015-06-24
SK284666B6 (sk) 2005-08-04
CZ20004254A3 (cs) 2001-12-12

Similar Documents

Publication Publication Date Title
US6479535B1 (en) 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
JP5872624B2 (ja) エストロゲンと組み合わせる２−フェニル−１−［４−（２−アミノエトキシ）ベンジルオキシ］インドール
US6326367B1 (en) 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
CZ117597A3 (en) Indole derivatives exhibiting estrogenic activity and pharmaceutical composition containing thereof
JP2002515484A (ja) ２−フェニルインドール化合物およびエストロゲン製剤からなる組成物
MXPA00011178A (en) 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens
HK1031691B (en) 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens